Carperitide (Genetical Recombination) for Injection 1000μg (HANP® / ハンプ注射用1000)

JPY ¥16,000

Japanese Alpha-type Human Atrial Natriuretic Polypeptide Preparation (Carperitide (Genetical Recombination) 1000μg). Lyophilized powder for continuous intravenous infusion in acute heart failure. 10 vials. Mfd. by Daiichi Sankyo Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥14,720
10 - 19 12% JPY ¥14,080
20 + 18% JPY ¥13,120
SKU: HNP-1000-INJ Category:

Description

Product Overview / 商品概要

HANP for Injection 1000μg (ハンプ注射用1000)
Generic: Carperitide (Genetical Recombination) / カルペリチド(遺伝子組換え)
Therapeutic Category: Alpha-type Human Atrial Natriuretic Polypeptide Preparation / α型ヒト心房性ナトリウム利尿ポリペプチド製剤
Manufactured by: Daiichi Sankyo Co., Ltd. / 第一三共株式会社

Composition & Specification / 組成・規格

Active Ingredient: Carperitide (Genetical Recombination) 1000μg per vial / 1バイアル中 カルペリチド(遺伝子組換え)1000μg
Additives: Purified sucrose 500mg / 精製白糖500mg
Appearance: White powder or mass; lyophilized powder for reconstitution. pH 4.5–6.5, osmotic pressure ratio (vs. normal saline) approximately 1 (when dissolved in 5mL water for injection).
外観: 白色の粉末又は塊 用時溶解して用いる凍結乾燥注射剤である。pH 4.5~6.5、浸透圧比(生理食塩液対比)約1(本剤1バイアルを注射用水5mLに溶解したとき)

Indications / 効能効果

EN: Acute heart failure (including acute exacerbation of chronic heart failure)
JA: 急性心不全(慢性心不全の急性増悪期を含む)

Dosage and Administration / 用法用量

EN: Dissolve in 5mL of Japanese Pharmacopoeia Water for Injection, and dilute with physiological saline or 5% glucose injection as needed. Administer by continuous intravenous infusion at 0.1μg/kg/min of carperitide. The dose may be adjusted while monitoring hemodynamics, and may be increased up to 0.2μg/kg/min according to the patient’s condition.
JA: 本剤は日本薬局方注射用水5mLに溶解し、必要に応じて日本薬局方生理食塩液又は5%ブドウ糖注射液で希釈し、カルペリチドとして1分間あたり0.1μg/kgを持続静脈内投与する。なお、投与量は血行動態をモニターしながら適宜調節するが、患者の病態に応じて1分間あたり0.2μg/kgまで増量できる。

Contraindications / 禁忌

EN: Patients with severe hypotension or cardiogenic shock; patients with right ventricular infarction; patients with dehydration
JA: 重篤な低血圧又は心原性ショックのある患者、右室梗塞のある患者、脱水症状の患者

Regulatory Information / 規制情報

Approval No.: 20700AMZ00027
Sales Started: May 1995 / 1995年5月
Classification Code: 872179
Storage: Store at room temperature / 室温保存
Shelf Life: 36 months / 36ヵ月

Packaging / 包装

Main Package (for sale): 10 vials / 10バイアル
Other Available Packages (by special order): 10 vials

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Carperitide (Genetical Recombination) for Injection 1000μg (HANP® / ハンプ注射用1000)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Carperitide (Genetical Recombination) for Injection 1000μg (HANP®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.